Follow the people · Insider
Phillip G. Febbo
Phillip G. Febbo files insider transactions with the SEC as a chief scientific & med officer of Veracyte (VCYT). We hold 2 disclosed purchases and sales filed since 17 February 2016, 1 of them in the last 90 days.
- Files forVCYT
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure4 September 2026
Positions held
4 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 2 October 2023 — 4 September 2026Chief Scientific & Med Officer · Veracyte (VCYT)31 Form 4 lines · source: SEC Form 4
- Filed 5 November 2019 — 1 March 2023SVP Chief Medical Officer · Illumina (ILMN)34 Form 4 lines · source: SEC Form 4
- Filed 14 February 2020 — 15 April 2021Director · Varian Medical Systems (VAR)9 Form 4 lines · source: SEC Form 4
- Filed 15 August 2015 — 20 February 2018Chief Medical Officer · Genomic Health (GHDX)23 Form 4 lines · source: SEC Form 4
Everything they disclosed
97 entries, newest first — one per disclosure report, one per Form 4 line- had shares withheld for tax on 3,639 shares of VeracyteSEC Form 44 September 2026Common Stock · traded 2 September 2026 · filed 4 September 2026
- ▼ sold on the open market 10,405 shares of VeracyteSEC Form 44 September 2026Common Stock · traded 4 September 2026 · filed 4 September 2026
- ▼ sold on the open market 2,705 shares of VeracyteSEC Form 44 September 2026Common Stock · traded 4 September 2026 · filed 4 September 2026
- had shares withheld for tax on 3,730 shares of VeracyteSEC Form 44 June 2026Common Stock · traded 2 June 2026 · filed 4 June 2026
- was granted 29,603 shares of VeracyteSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- was granted 6,578 shares of VeracyteSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- was granted 29,603 shares of VeracyteSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- was granted 6,578 shares of VeracyteSEC Form 410 March 2026Common Stock · traded 6 March 2026 · filed 10 March 2026
- had shares withheld for tax on 6,035 shares of VeracyteSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 13,425 shares of VeracyteSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- had shares withheld for tax on 6,035 shares of VeracyteSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- ▼ sold on the open market 13,425 shares of VeracyteSEC Form 44 March 2026Common Stock · traded 2 March 2026 · filed 4 March 2026
- was granted 71,806 shares of VeracyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 24,486 shares of VeracyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- was granted 71,806 shares of VeracyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 24,486 shares of VeracyteSEC Form 42 March 2026Common Stock · traded 26 February 2026 · filed 2 March 2026
- had shares withheld for tax on 2,955 shares of VeracyteSEC Form 44 December 2025Common Stock · traded 2 December 2025 · filed 4 December 2025
- ▼ sold on the open market 8,349 shares of VeracyteSEC Form 47 October 2025Common Stock · traded 6 October 2025 · filed 7 October 2025
- had shares withheld for tax on 2,955 shares of VeracyteSEC Form 44 September 2025Common Stock · traded 2 September 2025 · filed 4 September 2025
- had shares withheld for tax on 2,955 shares of VeracyteSEC Form 44 June 2025Common Stock · traded 2 June 2025 · filed 4 June 2025
- was granted 24,160 shares of VeracyteSEC Form 410 March 2025Common Stock · traded 6 March 2025 · filed 10 March 2025
- ▼ sold on the open market 4,467 shares of VeracyteSEC Form 46 March 2025Common Stock · traded 4 March 2025 · filed 6 March 2025
- ▼ sold on the open market 3,570 shares of VeracyteSEC Form 46 March 2025Common Stock · traded 4 March 2025 · filed 6 March 2025
- was granted 30,589 shares of VeracyteSEC Form 43 March 2025Common Stock · traded 27 February 2025 · filed 3 March 2025
- had shares withheld for tax on 15,672 shares of VeracyteSEC Form 43 March 2025Common Stock · traded 27 February 2025 · filed 3 March 2025
- had shares withheld for tax on 6,754 shares of VeracyteSEC Form 43 March 2025Common Stock · traded 2 March 2025 · filed 3 March 2025
- ▼ sold on the open market 3,934 shares of VeracyteSEC Form 46 December 2024Common Stock · traded 4 December 2024 · filed 6 December 2024
- had shares withheld for tax on 6,738 shares of VeracyteSEC Form 44 December 2024Common Stock · traded 2 December 2024 · filed 4 December 2024
- was granted 39,904 shares of VeracyteSEC Form 48 March 2024Common Stock · traded 6 March 2024 · filed 8 March 2024
- was granted 85,858 shares of Veracyte (a derivative holding)SEC Form 44 October 2023Stock Option (right to buy) · traded 2 October 2023 · filed 4 October 2023
- was granted 53,182 shares of VeracyteSEC Form 44 October 2023Common Stock · traded 2 October 2023 · filed 4 October 2023
- was granted 3,023 shares of Illumina (a derivative holding)SEC Form 43 March 2023Performance Shares · traded 1 March 2023 · filed 3 March 2023
- was granted 4,534 shares of Illumina (a derivative holding)SEC Form 43 March 2023Performance Shares · traded 1 March 2023 · filed 3 March 2023
- was granted 7,556 shares of IlluminaSEC Form 43 March 2023Common Stock · traded 1 March 2023 · filed 3 March 2023
- exercised options over 3,522 shares of Illumina (a derivative holding)SEC Form 423 February 2023Performance Shares · traded 21 February 2023 · filed 23 February 2023
- exercised options over 3,522 shares of IlluminaSEC Form 423 February 2023Common Stock · traded 21 February 2023 · filed 23 February 2023
- had shares withheld for tax on 1,245 shares of IlluminaSEC Form 423 February 2023Common Stock · traded 21 February 2023 · filed 23 February 2023
- had shares withheld for tax on 821 shares of IlluminaSEC Form 48 November 2022Common Stock · traded 5 November 2022 · filed 8 November 2022
- had shares withheld for tax on 131 shares of IlluminaSEC Form 47 April 2022Common Stock · traded 5 April 2022 · filed 7 April 2022
- ▼ sold on the open market 1,988 shares of IlluminaSEC Form 47 April 2022Common Stock · traded 6 April 2022 · filed 7 April 2022
- was granted 9,085 shares of Illumina (a derivative holding)SEC Form 43 March 2022Performance Shares · traded 1 March 2022 · filed 3 March 2022
- was granted 3,029 shares of IlluminaSEC Form 43 March 2022Common Stock · traded 1 March 2022 · filed 3 March 2022
- exercised options over 2,851 shares of Illumina (a derivative holding)SEC Form 424 February 2022Performance Shares · traded 22 February 2022 · filed 24 February 2022
- exercised options over 2,851 shares of IlluminaSEC Form 424 February 2022Common Stock · traded 22 February 2022 · filed 24 February 2022
- had shares withheld for tax on 1,002 shares of IlluminaSEC Form 424 February 2022Common Stock · traded 22 February 2022 · filed 24 February 2022
- had shares withheld for tax on 446 shares of IlluminaSEC Form 49 November 2021Common Stock · traded 5 November 2021 · filed 9 November 2021
- ▼ sold on the open market 1,000 shares of IlluminaSEC Form 49 November 2021Common Stock · traded 8 November 2021 · filed 9 November 2021
- ▼ sold on the open market 310 shares of IlluminaSEC Form 414 June 2021Common Stock · traded 11 June 2021 · filed 14 June 2021
- ▼ sold on the open market 400 shares of IlluminaSEC Form 414 June 2021Common Stock · traded 11 June 2021 · filed 14 June 2021
- ▼ sold on the open market 290 shares of IlluminaSEC Form 414 June 2021Common Stock · traded 11 June 2021 · filed 14 June 2021
- returned to the issuer 1,699 shares of Varian Medical SystemsSEC Form 416 April 2021Common Stock · traded 15 April 2021 · filed 16 April 2021
- returned to the issuer 1,022 shares of Varian Medical Systems (a derivative holding)SEC Form 416 April 2021Restricted Stock Units · traded 15 April 2021 · filed 16 April 2021
- had shares withheld for tax on 131 shares of IlluminaSEC Form 47 April 2021Common Stock · traded 5 April 2021 · filed 7 April 2021
- was granted 350 shares of IlluminaSEC Form 418 February 2021Common Stock · traded 17 February 2021 · filed 18 February 2021
- exercised options over 3,173 shares of IlluminaSEC Form 418 February 2021Common Stock · traded 17 February 2021 · filed 18 February 2021
- had shares withheld for tax on 1,454 shares of IlluminaSEC Form 418 February 2021Common Stock · traded 17 February 2021 · filed 18 February 2021
- exercised options over 3,173 shares of Illumina (a derivative holding)SEC Form 418 February 2021Performance Shares · traded 17 February 2021 · filed 18 February 2021
- exercised options over 1,225 shares of Varian Medical Systems (a derivative holding)SEC Form 417 February 2021Restricted Stock Units · traded 16 February 2021 · filed 17 February 2021
- exercised options over 1,225 shares of Varian Medical SystemsSEC Form 417 February 2021Common Stock · traded 16 February 2021 · filed 17 February 2021
- was granted 1,022 shares of Varian Medical Systems (a derivative holding)SEC Form 416 February 2021Restricted Stock Units · traded 11 February 2021 · filed 16 February 2021
- was granted 1,380 shares of IlluminaSEC Form 411 February 2021Common Stock · traded 9 February 2021 · filed 11 February 2021
- was granted 4,140 shares of Illumina (a derivative holding)SEC Form 411 February 2021Performance Shares · traded 9 February 2021 · filed 11 February 2021
- had shares withheld for tax on 192 shares of IlluminaSEC Form 49 November 2020Common Stock · traded 5 November 2020 · filed 9 November 2020
- ▼ sold on the open market 155 shares of IlluminaSEC Form 49 November 2020Common Stock · traded 6 November 2020 · filed 9 November 2020
- ▼ sold on the open market 173 shares of IlluminaSEC Form 420 April 2020Common Stock · traded 16 April 2020 · filed 20 April 2020
- had shares withheld for tax on 92 shares of IlluminaSEC Form 47 April 2020Common Stock · traded 5 April 2020 · filed 7 April 2020
- was granted 474 shares of Varian Medical Systems (a derivative holding)SEC Form 419 February 2020Restricted Stock Units · traded 14 February 2020 · filed 19 February 2020
- exercised options over 474 shares of Varian Medical Systems (a derivative holding)SEC Form 419 February 2020Restricted Stock Units · traded 14 February 2020 · filed 19 February 2020
- was granted 1,225 shares of Varian Medical Systems (a derivative holding)SEC Form 419 February 2020Restricted Stock Units · traded 14 February 2020 · filed 19 February 2020
- exercised options over 474 shares of Varian Medical SystemsSEC Form 419 February 2020Common Stock · traded 14 February 2020 · filed 19 February 2020
- was granted 3,746 shares of Illumina (a derivative holding)SEC Form 47 February 2020Performance Shares · traded 5 February 2020 · filed 7 February 2020
- was granted 1,249 shares of IlluminaSEC Form 47 February 2020Common Stock · traded 5 February 2020 · filed 7 February 2020
- ▼ sold on the open market 155 shares of IlluminaSEC Form 418 November 2019Common Stock · traded 14 November 2019 · filed 18 November 2019
- had shares withheld for tax on 83 shares of IlluminaSEC Form 47 November 2019Common Stock · traded 5 November 2019 · filed 7 November 2019
- ▼ sold on the open market 4,642 shares of Genomic HealthSEC Form 422 February 2018Common Stock · traded 20 February 2018 · filed 22 February 2018
- ▼ sold on the open market 300 shares of Genomic HealthSEC Form 422 February 2018Common Stock · traded 20 February 2018 · filed 22 February 2018
- had shares withheld for tax on 2,801 shares of Genomic HealthSEC Form 420 February 2018Common Stock · traded 15 February 2018 · filed 20 February 2018
- was granted 11,330 shares of Genomic HealthSEC Form 42 February 2018Common Stock · traded 31 January 2018 · filed 2 February 2018
- was granted 26,060 shares of Genomic Health (a derivative holding)SEC Form 42 February 2018Employee Stock Option (right to buy) Holding · traded 31 January 2018 · filed 2 February 2018
- exercised options over 5,000 shares of Genomic HealthSEC Form 420 December 2017Common Stock · traded 19 December 2017 · filed 20 December 2017
- ▼ sold on the open market 5,000 shares of Genomic HealthSEC Form 420 December 2017Common Stock · traded 19 December 2017 · filed 20 December 2017
- ▼ sold on the open market 334 shares of Genomic HealthSEC Form 420 December 2017Common Stock · traded 19 December 2017 · filed 20 December 2017
- exercised options over 5,000 shares of Genomic Health (a derivative holding)SEC Form 420 December 2017Employee Stock Option (right to buy) Holding · traded 19 December 2017 · filed 20 December 2017
- ▼ sold on the open market 2,844 shares of Genomic HealthSEC Form 421 July 2017Common Stock · traded 19 July 2017 · filed 21 July 2017
- ▼ sold on the open market 330 shares of Genomic HealthSEC Form 421 July 2017Common Stock · traded 19 July 2017 · filed 21 July 2017
- had shares withheld for tax on 1,910 shares of Genomic HealthSEC Form 417 February 2017Common Stock · traded 15 February 2017 · filed 17 February 2017
- ▼ sold on the open market 1,269 shares of Genomic HealthSEC Form 417 February 2017Common Stock · traded 16 February 2017 · filed 17 February 2017
- ▼ sold on the open market 1,226 shares of Genomic HealthSEC Form 417 February 2017Common Stock · traded 16 February 2017 · filed 17 February 2017
- was granted 11,440 shares of Genomic HealthSEC Form 42 February 2017Common Stock · traded 31 January 2017 · filed 2 February 2017
- was granted 26,320 shares of Genomic Health (a derivative holding)SEC Form 42 February 2017Employee Stock Option (right to buy) Holding · traded 31 January 2017 · filed 2 February 2017
- had shares withheld for tax on 1,065 shares of Genomic HealthSEC Form 420 December 2016Common Stock · traded 15 August 2015 · filed 20 December 2016
- had shares withheld for tax on 1,066 shares of Genomic HealthSEC Form 420 December 2016Common Stock · traded 15 August 2016 · filed 20 December 2016
- ▼ sold on the open market 6,224 shares of Genomic HealthSEC Form 412 May 2016Common Stock · traded 10 May 2016 · filed 12 May 2016
- ▼ sold on the open market 100 shares of Genomic HealthSEC Form 412 May 2016Common Stock · traded 10 May 2016 · filed 12 May 2016
- had shares withheld for tax on 1,255 shares of Genomic HealthSEC Form 417 February 2016Common Stock · traded 15 February 2016 · filed 17 February 2016
- was granted 7,290 shares of Genomic HealthSEC Form 417 February 2016Common Stock · traded 16 February 2016 · filed 17 February 2016
- was granted 14,710 shares of Genomic Health (a derivative holding)SEC Form 417 February 2016Employee Stock Option (right to buy) Holding · traded 16 February 2016 · filed 17 February 2016
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.